Literature DB >> 2470945

Clinico-histochemical studies on type 4 carcinoma of the stomach--with special reference to mucopolysaccharides and sialic acid in tumor tissue.

M Sowa1, Y Kato, M Nishimura, H Yoshino, T Kubo, K Umeyama.   

Abstract

One hundred and twenty-one patients with gastric cancer of Borrman IV (type 4) were classified into two types according to the macroscopic appearance of their tumors, namely, those tumors with giant folds (type G, n = 84) and those without giant folds (type P, n = 37). A large percentage of the cases in both type groups had advanced stage carcinoma. Type G was found to be predominant in young women and the incidence of high-grade lymph node metastasis was higher in type G than in type P. Histochemically, it was shown that the tumor interstitium of type G contained obviously many more acid mucopolysaccharides (AMPS) than the localized Borrman II (type 2) gastric cancer, which was used as a control. The results of enzymatic digestion tests suggested that the amounts of hyaluronic acid, chondroitin sulfate, and sialic acid were greater in type G than in type P or the localized type, the differences involved being marked between type G and the localized type.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2470945     DOI: 10.1007/bf02471579

Source DB:  PubMed          Journal:  Jpn J Surg        ISSN: 0047-1909


  16 in total

1.  [Connective tissues and diseases 3. neoplasma and acid mucopolysaccharides].

Authors:  T Koizumi; N Nakamura
Journal:  Nihon Rinsho       Date:  1975-05-10

2.  Growth-promoting activity of acid mucopolysaccharides on a strain of human mammary carcinoma cells.

Authors:  L OZZELLO; E Y LASFARGUES; M R MURRAY
Journal:  Cancer Res       Date:  1960-06       Impact factor: 12.701

Review 3.  The biochemical and histochemical nomenclature of mucus.

Authors:  L Reid; J R Clamp
Journal:  Br Med Bull       Date:  1978-01       Impact factor: 4.291

4.  Acid mucopolysaccharides and cirrhosis of the liver.

Authors:  J T Galambos
Journal:  Gastroenterology       Date:  1966-07       Impact factor: 22.682

5.  [A clinical pathological study on the patterns of development of gastric cancer of Borrmann 4 type--with special reference to the pictures of lymphatic permeation (author's transl)].

Authors:  H Nomura; M Nishi
Journal:  Nihon Shokakibyo Gakkai Zasshi       Date:  1979-04

6.  [Serum levels of sialic acid and other glycoproteins in stomach cancer, with special reference to cellular immunity].

Authors:  K Ogoshi; Y Kondoh; T Tajima; T Mitomi
Journal:  Nihon Shokakibyo Gakkai Zasshi       Date:  1983-11

7.  [A histochemical study of the intracytoplasmic mucosubstances on chronic pancreatitis and pancreatic carcinoma (author's transl)].

Authors:  O Ishikawa; Y Matsui; Y Aoki; T Iwanaga; T Terasawa; A Wada; R Tateishi; H Akedo
Journal:  Nihon Shokakibyo Gakkai Zasshi       Date:  1980-10

8.  [Pathology and histogenesis of gastric scirrhous carcinoma].

Authors:  I Kino
Journal:  Gan No Rinsho       Date:  1984-05

9.  [Extension modes in Borrmann-4 stomach carcinoma estimated by macroscopic appearances].

Authors:  T Iwanaga; H Furukawa; H Taniguchi; S Ishiguro
Journal:  Gan No Rinsho       Date:  1983-02

10.  Increased synthesis of hyaluronic acid by mouse mammary carcinoma cell variants with high metastatic potential.

Authors:  K Kimata; Y Honma; M Okayama; K Oguri; M Hozumi; S Suzuki
Journal:  Cancer Res       Date:  1983-03       Impact factor: 12.701

View more
  10 in total

1.  RhoA/ROCK signaling mediates plasticity of scirrhous gastric carcinoma motility.

Authors:  Tasuku Matsuoka; Masakazu Yashiro; Yukihiro Kato; Osamu Shinto; Shinichiro Kashiwagi; Kosei Hirakawa
Journal:  Clin Exp Metastasis       Date:  2011-06-12       Impact factor: 5.150

2.  Role of alpha 2 beta 1- and alpha 3 beta 1-integrin in the peritoneal implantation of scirrhous gastric carcinoma.

Authors:  S Nishimura; Y S Chung; M Yashiro; T Inoue; M Sowa
Journal:  Br J Cancer       Date:  1996-11       Impact factor: 7.640

3.  Adhesion polypeptides are useful for the prevention of peritoneal dissemination of gastric cancer.

Authors:  T Matsuoka; K Hirakawa; Y S Chung; M Yashiro; S Nishimura; T Sawada; I Saiki; M Sowa
Journal:  Clin Exp Metastasis       Date:  1998-05       Impact factor: 5.150

4.  Elevated dietary linoleic acid increases gastric carcinoma cell invasion and metastasis in mice.

Authors:  T Matsuoka; J E Adair; F B Lih; L C Hsi; M Rubino; T E Eling; K B Tomer; M Yashiro; K Hirakawa; K Olden; J D Roberts
Journal:  Br J Cancer       Date:  2010-09-14       Impact factor: 7.640

5.  Analysis of the expression of hyaluronan in intraductal and invasive carcinomas of the breast.

Authors:  Maria Daniela Corte; Luis Ovidio González; Sara Junquera; Miguel Bongera; Maria Teresa Allende; Francisco José Vizoso
Journal:  J Cancer Res Clin Oncol       Date:  2009-11-07       Impact factor: 4.553

6.  PI3K/Akt signalling is required for the attachment and spreading, and growth in vivo of metastatic scirrhous gastric carcinoma.

Authors:  T Matsuoka; M Yashiro; N Nishioka; K Hirakawa; K Olden; J D Roberts
Journal:  Br J Cancer       Date:  2012-04-24       Impact factor: 7.640

7.  Hyaluronan expression in gastric cancer cells is associated with local and nodal spread and reduced survival rate.

Authors:  L P Setälä; M I Tammi; R H Tammi; M J Eskelinen; P K Lipponen; U M Agren; J Parkkinen; E M Alhava; V M Kosma
Journal:  Br J Cancer       Date:  1999-03       Impact factor: 7.640

8.  CD44H plays an important role in peritoneal dissemination of scirrhous gastric cancer cells.

Authors:  S Nishimura; Y S Chung; M Yashiro; T Inoue; M Sowa
Journal:  Jpn J Cancer Res       Date:  1996-12

9.  Globotriaosyl ceramide and globoside as major glycolipid components of fibroblasts in scirrhous gastric carcinoma tissues.

Authors:  R Sawada; H Hotta; Y S Chung; M Sowa; T Tai; I Yano
Journal:  Jpn J Cancer Res       Date:  1998-02

10.  Proliferative activity as a prognostic factor in Borrmann type 4 gastric carcinoma.

Authors:  Y Kakeji; Y Maehara; Y Adachi; H Baba; M Mori; M Furusawa; K Sugimachi
Journal:  Br J Cancer       Date:  1994-04       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.